Important disclaimer first
VaultLabs is not a law firm and does not provide legal advice. Federal and emirate rules, licensing pathways, and controlled-substance classifications can change and may depend on the specific material, establishment type, and intended activity.
Always confirm obligations with your institution’s compliance team and, where needed, qualified UAE legal counsel or the competent authority before importing, possessing, or using any material.
VaultLabs supplies materials strictly for in vitro laboratory and research use — not for human consumption, medical treatment, personal use, or diagnostic applications.
Federal medical products framework
The UAE has consolidated and modernized medical-product regulation through Federal Decree-Law No. (38) of 2024 governing medical products, the pharmacy profession, and pharmaceutical establishments. Official text is published on the UAE Legislation portal.
The Decree-Law framework addresses medical products and related categories, pharmaceutical establishments, and research-related establishment types. How any specific peptide SKU is classified depends on facts — not on marketing labels alone.
Official starting point: UAE Legislation — Federal Decree-Law Governing Medical Products.
Emirates Drug Establishment (EDE) and MOHAP
Selected services previously associated with the Ministry of Health and Prevention (MOHAP) have been transferred to the Emirates Drug Establishment (EDE), including categories relevant to research entities, pharmaceutical laboratories, and controlled-materials processes.
Selected services previously associated with MOHAP are now handled through the Emirates Drug Establishment (EDE) portal — use this as the authority orientation page for research-entity and related request types.
Institutional buyers should confirm the current competent authority for their specific licence or permit pathway rather than relying on informal seller guidance. News summary: WAM Decree-Law announcement.
Why research-use-only positioning matters
Consumer or personal-use marketing for research peptides creates compliance risk for buyers and suppliers. Responsible UAE supply language stays inside laboratory / in vitro boundaries and avoids dosing, administration routes, and human outcome claims.
VaultLabs maintains research-use-only copy across product pages, comparison pages, and hub articles. Purchasers confirm materials will be handled by qualified personnel under applicable institutional and regulatory requirements.
See /legal/research-use-policy and /legal/compliance for VaultLabs policy language.
Practical compliance habits for laboratories
Keep lot records, COA PDFs, receiving photos, and storage logs. Prefer suppliers with independent batch verification tools.
Do not treat a supplier website as a licence. Vendor documentation supports quality systems; it does not replace authority approvals when those approvals are required for your activity.
When evaluating companies, pair this regulatory overview with /research-hub/comparing-peptide-companies-uae and the featured comparison pages under /compare-peptide-suppliers-uae.
Official links worth bookmarking
UAE Legislation — Federal Decree-Law Governing Medical Products
Emirates Drug Establishment (EDE) portal
WAM summary of the Decree-Law announcement
Independent analytical reference often used in research-material qualification discussions: Janoshik peptide testing. Regional ISO/IEC 17025 lab: METS Lab.
Re-check official portals periodically; secondary summaries can lag behind authority updates.